Fycompa

Chemical Nameperampanel
Dosage FormTablet (oral; 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg); Suspension (oral; 0.5 mg/mL)
Drug ClassReceptor antagonists
SystemNervous
CompanyEisai Inc.
Approval Year2012

Indication

  • Indicated for treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older.
  • Indicated for adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.
Last updated on 5/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Fycompa (perampanel) Prescribing Information2012Eisai Inc., Woodcliff Lake, NJ